A Preview Of Organogenesis Hldgs's Earnings
Portfolio Pulse from Benzinga Insights
Organogenesis Hldgs (NASDAQ:ORGO) is set to release its quarterly earnings report on Thursday, 2024-02-29, with an estimated EPS of $0.01. Historical data shows the company has previously beaten EPS estimates, leading to significant share price movements. Shares are currently trading at $3.58, up 29.41% over the last 52 weeks, indicating a positive outlook from long-term shareholders.
February 28, 2024 | 7:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Organogenesis Hldgs is expected to report an EPS of $0.01 for the upcoming quarterly earnings. Historical performance shows significant price movements post-earnings, with shares currently up 29.41% over the last year.
Given Organogenesis Hldgs's history of beating EPS estimates and the subsequent positive impact on its stock price, there is a strong likelihood of a positive short-term price movement if the company beats the EPS estimate again. The historical data provided shows a clear correlation between earnings performance and stock price movements, suggesting investor confidence in the company's financial health.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100